More info
Active ingredients
Interferon gamma
Pharmacological effect
The drug that activates antiviral immunity. With prophylactic and therapeutic use of the drug has an immunomodulatory and antiviral effect. Efficacy against influenza viruses (including avian influenza), parainfluenza, herpes simplex viruses of types 1 and 2 (labial herpes, genital herpes), other herpes viruses (chickenpox, infectious mononucleosis), enteroviruses, tick-borne virus has been experimentally and clinically established. encephalitis, rotavirus, coronavirus, calicivirus, adenovirus, respiratory syncytial (PC virus). The drug reduces the concentration of virus in the affected tissues, affects the system of endogenous interferons and associated cytokines, induces the formation of endogenous "early" interferon (IFN α /) and gamma interferon (IFN). Stimulates the humoral and cellular immune response. It increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers (Tx), normalizes their ratio. Increases the functional reserve of Tx and other cells involved in the immune response. It is an inducer of the mixed Tx1 and Tx2-type immune response: it increases the production of cytokines Tx1 (IFN, IL-2) and Tx2 (IL-4, 10), normalizes (modulates) the balance of Tx1 / Tx2 activities. Increases the functional activity of phagocytes and natural killer cells (EC cells). It has antimutagenic properties.
Indications
- prevention and treatment of acute respiratory viral infections (including influenza); - complex therapy of infections caused by herpes viruses (infectious mononucleosis, chicken pox, labial herpes, genital herpes); - complex therapy and prevention of recurrence of chronic herpes virus infection, including labial and genital herpes; - complex therapy and prevention of other acute and chronic viral infections caused by tick-borne encephalitis virus, enterovirus, rotavirus, coronavirus, calicivirus; - as part of complex therapy of bacterial infections; - complex therapy of secondary immunodeficiency states of various etiologies, including the prevention and treatment of complications of viral and bacterial infections.
Contraindications
- children's age up to 1 month; - increased individual sensitivity to the components of the drug.
Use during pregnancy and lactation
The safety of using Anaferona Infant during pregnancy and lactation has not been studied. If necessary, taking the drug should consider the ratio of risk / benefit.
Side effects
When using the drug for the indicated indications and in the indicated dosages, no side effects were revealed. Possible manifestations of increased individual sensitivity to the components of the drug.
Overdose
Cases of overdose so far not registered. In case of accidental overdose, dyspeptic symptoms are possible due to the fillers in the preparation.
Interaction with other drugs
Cases of incompatibility with other drugs to date has not been identified. If necessary, the drug can be combined with other antiviral, antibacterial and symptomatic agents.
special instructions
The preparation contains lactose, therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose malabsorption syndrome or in congenital lactase deficiency.